Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
Src/Bcr Abl
  • PDGFR
  • c Kit
  >   Imatinib mesylate
Imatinib mesylate Chemical Structure

Imatinib mesylate

Data Sheet For research use only. Not for human use.
Cat. No. :BCP01255CAS No. :220127-57-1Purity:98%
 Tel: 0086-13026320035   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 220127-57-1 Cat. No. BCP01255
Name Imatinib mesylate
Synonyms STI571 Mesylate; CGP-57148B Mesylate;CGP 57148; CGP57148; CGP-57148; CGP57148B; CGP-57148B; CGP 57148B; STI571; STI-571; STI 571;
SMILES
Chemical Name
Formula C29H31N7O.CH4O3S M. Wt 589.71
Purity 98% Storage Store at 4-8°C
Description Imatinib Mesylate is the mesylate salt of imatinib, a tyrosine kinase inhibitor with antineoplastic activity. Imatinib binds to an intracellular pocket located within tyrosine kinases (TK), thereby inhibiting ATP binding and preventing phosphorylation and the subsequent activation of growth receptors and their downstream signal transduction pathways. This agent inhibits TK encoded by the bcr-abl oncogene as well as receptor TKs encoded by the c-kit and platelet-derived growth factor receptor (PDGFR) oncogenes. Inhibition of the bcr-abl TK results in decreased proliferation and enhanced apoptosis in malignant cells of Philadelphia-positive (Ph+) hematological malignancies such as CML and ALL; effects on c-kit TK activity inhibit mast-cell and cellular proliferation in those diseases overexpressing c-kit, such as mastocytosis and gastrointestinal stromal tumor (GIST).
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Imatinib mesylate supplier,Imatinib mesylate purchase,Imatinib mesylate manufacturer,Imatinib mesylate distributor,Imatinib mesylate cost,Imatinib mesylate buy,Imatinib mesylate for sale

0086-13720134139